Telix Pharmaceuticals Limited (ASX:TLX)

Telix Pharmaceuticals Statistics

Total Valuation

ASX:TLX has a market cap or net worth of AUD 4.96 billion. The enterprise value is 5.45 billion.

Market Cap	4.96B
Enterprise Value	5.45B

Important Dates

The next estimated earnings date is Wednesday, August 19, 2026.

Earnings Date	Aug 19, 2026
Ex-Dividend Date	n/a

Share Statistics

ASX:TLX has 339.11 million shares outstanding. The number of shares has decreased by -2.12% in one year.

Current Share Class	339.11M
Shares Outstanding	339.11M
Shares Change (YoY)	-2.12%
Shares Change (QoQ)	+0.40%
Owned by Insiders (%)	14.88%
Owned by Institutions (%)	42.36%
Float	272.90M

Valuation Ratios

PE Ratio	n/a
Forward PE	555.11
PS Ratio	4.12
PB Ratio	7.97
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	14.73

Enterprise Valuation

The stock's EV/EBITDA ratio is 90.39, with an EV/FCF ratio of -84.61.

EV / Earnings	-510.42
EV / Sales	4.52
EV / EBITDA	90.39
EV / EBIT	188.56
EV / FCF	-84.61

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 1.12.

Current Ratio	1.43
Quick Ratio	1.21
Debt / Equity	1.12
Debt / EBITDA	11.61
Debt / FCF	-10.87
Interest Coverage	1.40

Financial Efficiency

Return on equity (ROE) is -1.85% and return on invested capital (ROIC) is 2.60%.

Return on Equity (ROE)	-1.85%
Return on Assets (ROA)	1.15%
Return on Invested Capital (ROIC)	2.60%
Return on Capital Employed (ROCE)	2.07%
Weighted Average Cost of Capital (WACC)	6.94%
Revenue Per Employee	1.05M
Profits Per Employee	-9,272
Employee Count	1,184
Asset Turnover	0.76
Inventory Turnover	13.90

Taxes

In the past 12 months, ASX:TLX has paid 2.79 million in taxes.

Income Tax	2.79M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -43.41% in the last 52 weeks. The beta is 0.61, so ASX:TLX's price volatility has been lower than the market average.

Beta (5Y)	0.61
52-Week Price Change	-43.41%
50-Day Moving Average	11.50
200-Day Moving Average	14.61
Relative Strength Index (RSI)	61.18
Average Volume (20 Days)	3,575,216

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, ASX:TLX had revenue of AUD 1.21 billion and -10.68 million in losses. Loss per share was -0.03.

Revenue	1.21B
Gross Profit	572.46M
Operating Income	28.92M
Pretax Income	-7.89M
Net Income	-10.68M
EBITDA	48.66M
EBIT	28.92M
Loss Per Share	-0.03

Balance Sheet

The company has 212.69 million in cash and 700.29 million in debt, with a net cash position of -487.60 million or -1.44 per share.

Cash & Cash Equivalents	212.69M
Total Debt	700.29M
Net Cash	-487.60M
Net Cash Per Share	-1.44
Equity (Book Value)	622.73M
Book Value Per Share	1.84
Working Capital	147.91M

Cash Flow

In the last 12 months, operating cash flow was -25.93 million and capital expenditures -38.52 million, giving a free cash flow of -64.44 million.

Operating Cash Flow	-25.93M
Capital Expenditures	-38.52M
Depreciation & Amortization	18.36M
Net Borrowing	-7.70M
Free Cash Flow	-64.44M
FCF Per Share	-0.19

Margins

Gross margin is 47.51%, with operating and profit margins of 2.40% and -0.89%.

Gross Margin	47.51%
Operating Margin	2.40%
Pretax Margin	-0.66%
Profit Margin	-0.89%
EBITDA Margin	4.04%
EBIT Margin	2.40%
FCF Margin	n/a

Dividends & Yields

ASX:TLX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	2.12%
Shareholder Yield	2.12%
Earnings Yield	-0.22%
FCF Yield	-1.30%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ASX:TLX has an Altman Z-Score of 4.4 and a Piotroski F-Score of 2.

Altman Z-Score	4.4
Piotroski F-Score	2